Having trouble accessing articles? Reset your cache.

Tecfidera dimethyl fumarate regulatory update

FDA approved Tecfidera dimethyl fumarate from Biogen Idec to treat adults with relapsing forms of multiple sclerosis. Tecfidera's label includes a warning about lymphopenia and recommends health care providers assess a patient's complete blood cell count before and during treatment, but the label does

Read the full 445 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE